GPT Healthcare Ltd Q2 FY26 – 719 Beds, 5 Hospitals, and One Chairman Less: The Hospital Chain That’s Running at 53% Occupancy but 100% Drama
1. At a Glance
When you think of healthcare in Eastern India, GPT Healthcare Ltd — the operator of the ILS Hospitals brand — probably pops up right after your blood pressure reading. With a ₹1,213 crore market cap and a ₹148 share price (as of Nov 7, 2025), the company has managed to stitch a clean surgical gown around consistent revenue growth — ₹430 crore in FY25 with a healthy ₹43 crore profit. But let’s be honest, investors are still waiting for this patient to get off the ventilator of flat margins.
In Q2 FY26, the company reported ₹228.9 crore H1 revenue and ₹18.3 crore PAT — down about 28.5% QoQ on profit. The company’s EBITDA margin remains at a decent 19%, with an ROCE of 27.2% and ROE at 21.3%. It also announced a 10% interim dividend (₹1/share), just to remind everyone that despite the emotional turbulence of its Chairman’s unfortunate passing, business continues as usual.
So yes, GPT Healthcare isn’t exactly Apollo Hospitals, but in the smaller eastern corridors — from Kolkata to Agartala to Raipur — this ₹148 stock is quietly trying to run a profitable hospital chain at an affordable capex of ₹7–8 million per bed. The financials are healthy enough, but the question is — can it sustain the pulse rate?
2. Introduction
India’s hospital game is split between two species — the giant corporate beasts like Apollo and Fortis, who charge you for the oxygen you breathe in the waiting room, and the nimble regional specialists like GPT Healthcare, who try to balance quality care with affordability.
GPT Healthcare operates 5 multi-specialty hospitals under the “ILS Hospitals” brand across Eastern India. These facilities — Salt Lake, Dum Dum, Howrah, Agartala, and Raipur — together form a 719-bed empire that thrives on smart capital deployment and local dominance.
FY25 was a bittersweet year. On one hand, the company’s revenue rose to ₹430 crore with a ₹43 crore PAT. On the other, it lost its veteran Executive Chairman Dwarika Prasad Tantia in August 2025. Leadership transitions followed, and yet, the business didn’t flatline. The board immediately elevated Shree Gopal Tantia as the new Chairman, and the hospital network continued expanding.
GPT’s story isn’t one of exponential growth — it’s one of strategic survival. The company has kept a steady pulse even as its larger peers were performing cardiac surgeries on their P&L statements. But can a small regional chain stay healthy when industry giants are pumping in billions into Tier-II healthcare?
3. Business Model – WTF Do They Even Do?
Let’s put it simply — GPT Healthcare runs hospitals. But unlike the ultra-glamorous “boutique” healthcare chains that make you feel like you’re checking into a 5-star resort, GPT runs hospitals that actually treat patients instead of Instagramming their lobbies.
Under the ILS Hospitals banner, GPT operates five multi-specialty hospitals offering treatments across nephrology, diabetology, general surgery, gynecology, orthopedics, and more. Their specialties are backed by 91 full-time consultants and over 570 visiting consultants.
Each hospital plays its own tune:
Dum Dum is the overachiever — ₹161.7 crore revenue with 69% occupancy and ₹41,183 ARPOB (Average Revenue Per Occupied Bed).
Salt Lake brings in ₹70.9 crore with 58.1% occupancy, excelling in bariatric and robotic surgery.
Agartala is the regional hero — ₹117.5 crore revenue with a Cancer Care Department under construction.
Howrah is the quiet cousin — ₹57 crore revenue, 41% occupancy.
Raipur, the newest baby, cost ₹74 crore to set up and runs on a rental-based, asset-light model.
The company treats about 30,783 in-patients and 1.59 lakh out-patients annually — impressive numbers for a focused regional operator. Their occupancy rate of 53.1%, while modest, is cushioned by an ARPOB of ₹37,180 and an ALOS (Average Length of Stay) of 3.54 days — healthy metrics for mid-tier hospitals.
Basically, GPT’s formula is simple — expand using rental properties, optimize capex, and grow beds faster than Apollo can open cafeterias.
4. Financials Overview
Metric
Latest Qtr (Sep’25)
YoY Qtr (Sep’24)
Prev Qtr (Jun’25)
YoY %
QoQ %
Revenue
₹119 Cr
₹106 Cr
₹107 Cr
12.3%
11.2%
EBITDA
₹23 Cr
₹23 Cr
₹17 Cr
0%
35.3%
PAT
₹11 Cr
₹15 Cr
₹8 Cr
-26.7%
37.5%
EPS (₹)
1.29
1.81
0.94
-28.7%
37.2%
Annualized EPS: ₹5.16 → P/E ~ 28.6x
Commentary: Revenue growth is there, but profit margins seem to have caught a seasonal flu. While the EBITDA margin holds around 19%, the drop in PAT YoY shows the pressure of expansion costs and the Raipur commissioning. Still, the operating profit bandages are strong enough — no signs of financial hemorrhage yet.
5. Valuation Discussion – Fair Value Range
Method 1: P/E Based Valuation Current EPS = ₹5.29 Industry P/E = 55.2 Company P/E = 27.9 If GPT trades at 25x–35x range (reasonable for mid-tier hospitals): Fair Value = ₹132 – ₹185
Method 2: EV/EBITDA EV = ₹1,308 Cr EBITDA = ₹82 Cr EV/EBITDA = 15.9x (vs sector average 18–22x) If re-rated to 18x → EV = ₹1,476 Cr → Equity Value = ₹1,379 Cr → ₹168/share
✅ Fair Value Range: ₹150 – ₹185/share (For educational purposes only, not investment advice)
6. What’s Cooking – News, Triggers, Drama
August to November 2025 was peak drama season.
Chairman Dwarika Prasad Tantia passed away on August 17, 2025. The board moved swiftly, appointing Shree Gopal Tantia as Chairman. Operations continued seamlessly — a rare case of a family-run business not going into ICU after a patriarch’s passing.
